BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $125,572,000 | +3.7% | 830,668 | -0.0% | 0.13% | +12.4% |
| Q2 2022 | $121,052,000 | -11.4% | 830,776 | -27.9% | 0.11% | +9.7% |
| Q1 2022 | $136,572,000 | +13.6% | 1,151,829 | +32.0% | 0.10% | +25.6% |
| Q4 2021 | $120,249,000 | -0.7% | 872,570 | +0.1% | 0.08% | -4.7% |
| Q3 2021 | $121,098,000 | +42.7% | 871,776 | -0.3% | 0.09% | +45.8% |
| Q2 2021 | $84,878,000 | +64.0% | 874,314 | +15.4% | 0.06% | +51.3% |
| Q1 2021 | $51,764,000 | +13.2% | 757,340 | +41.9% | 0.04% | +11.4% |
| Q4 2020 | $45,738,000 | +90.6% | 533,631 | +44.6% | 0.04% | +66.7% |
| Q3 2020 | $23,999,000 | +17.5% | 369,156 | +32.2% | 0.02% | +16.7% |
| Q2 2020 | $20,423,000 | – | 279,345 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |